Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP
- 1 October 1995
- journal article
- research article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 55 (1), 67-76
- https://doi.org/10.1016/0960-0760(95)00155-s
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The effect of dihydrotestosterone and culture conditions on proliferation of the human prostatic cancer cell line LNCaPSteroids, 1992
- Carcinoma of the ProstateNew England Journal of Medicine, 1991
- A mutation in the ligand binding domain of the androgen receptor of human INCaP cells affects steroid binding characteristics and response to anti-androgensBiochemical and Biophysical Research Communications, 1990
- The Proliferative Effect of “Anti-Androgens” on the Androgen-Sensitive Human Prostate Tumor Cell Line LNCaPEndocrinology, 1990
- The human prostatic carcinoma cell line LNCaP and its derivativesUrological Research, 1989
- Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroidsInternational Journal of Cancer, 1988
- Androgens and transforming growth factor β modulate the growth response to epidermal growth factor in human prostatic tumor cells (LNCaP)Molecular and Cellular Endocrinology, 1988
- Androgen‐dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaPThe Prostate, 1985
- Effect of hormones on growth and ATP content of a human prostatic carcinoma cell line, LNCaP‐rThe Prostate, 1985
- Dual effects of estradiol on normal and tumor pituitary cell multiplicationJournal of Steroid Biochemistry, 1984